Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Whitehawk Therapeutics (WHWK) Return on Sales (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Return on Sales for 8 consecutive years, with 0.27% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 279.0% to 0.27% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.27% through Dec 2025, up 272.0% year-over-year, with the annual reading at 2.88% for FY2025, 43.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.27% at Whitehawk Therapeutics, up from 7.17% in the prior quarter.
  • The five-year high for Return on Sales was 0.27% in Q4 2025, with the low at 276.33% in Q3 2021.
  • Average Return on Sales over 5 years is 18.74%, with a median of 2.7% recorded in 2022.
  • The sharpest move saw Return on Sales plummeted -26381bps in 2021, then skyrocketed 27292bps in 2022.
  • Over 5 years, Return on Sales stood at 1.14% in 2021, then crashed by -133bps to 2.66% in 2022, then rose by 3bps to 2.57% in 2023, then grew by 2bps to 2.52% in 2024, then skyrocketed by 111bps to 0.27% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.27%, 7.17%, and 4.54% for Q4 2025, Q3 2025, and Q2 2025 respectively.